scholarly article | Q13442814 |
P356 | DOI | 10.2215/CJN.00620115 |
P8608 | Fatcat ID | release_gcvlht7dzfa6xh3blgpr2bmpye |
P932 | PMC publication ID | 4594056 |
P698 | PubMed publication ID | 26408549 |
P50 | author | Nina Ajmone Marsan | Q79465156 |
Martin Jan Schalij | Q89053249 | ||
Jeroen Joost Bax | Q77085900 | ||
P2093 | author name string | Victoria Delgado | |
Enno T van der Velde | |||
Ulas Höke | |||
Mand J H Khidir | |||
P2860 | cites work | Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy | Q78039342 |
Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy | Q82404923 | ||
Renal function and mortality following cardiac resynchronization therapy | Q82414338 | ||
Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure | Q83345954 | ||
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease) | Q84143572 | ||
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study | Q28167204 | ||
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ | Q33162947 | ||
Importance of venous congestion for worsening of renal function in advanced decompensated heart failure | Q33799478 | ||
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, | Q34125322 | ||
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure | Q34321811 | ||
Recommendations for chamber quantification | Q34491436 | ||
Cardiac resynchronization therapy in the cardiorenal syndrome | Q35055236 | ||
Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? | Q36357265 | ||
Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy | Q36720290 | ||
Cardiac resynchronization therapy in CKD: a systematic review | Q37065585 | ||
Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate | Q37280350 | ||
Cardiorenal syndrome | Q37324890 | ||
Device therapy in heart failure patients with chronic kidney disease | Q37919633 | ||
Effects of cardiac resynchronization therapy on systemic inflammation and neurohormonal pathways in heart failure | Q43233275 | ||
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure | Q43500856 | ||
Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. | Q45929238 | ||
Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy | Q47884470 | ||
Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment | Q47955730 | ||
Hemodynamic changes during cardiac resynchronization therapy | Q48228451 | ||
The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiography. | Q50673814 | ||
Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. | Q50731032 | ||
Prognostic value of renal function in patients with cardiac resynchronization therapy. | Q51093345 | ||
Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops. | Q51252076 | ||
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. | Q51590015 | ||
Impaired Renal Function Is Associated With Echocardiographic Nonresponse and Poor Prognosis After Cardiac Resynchronization Therapy | Q57299447 | ||
Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency. | Q64983685 | ||
Clinical classification of cardiac deaths | Q70271211 | ||
Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure | Q73199514 | ||
P433 | issue | 10 | |
P304 | page(s) | 1740-1748 | |
P577 | publication date | 2015-09-25 | |
P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
P1476 | title | Cardiac Resynchronization Therapy in CKD Stage 4 Patients | |
P478 | volume | 10 |
Q43232841 | Cardiorenal Resynchronization Therapy: Strengthening the Heart and Kidneys |
Q90602756 | Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients |
Q46160078 | Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function |
Q39019268 | Publication trends in cachexia and sarcopenia in elderly heart failure patients |
Search more.